Skip to search formSkip to main contentSkip to account menu

NE 10790

Known as: NE-10790, NE10790 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Prevention of transplant coronary artery disease by prenylation inhibitors.
2004
2004
NE10790, a phosphonocarboxylate analogue of risedronate, induces human myeloma cell apoptosis in vitro
2004
2004
Risedronate, and its phosphonocarboxylate analogue NE10790, both induce apoptosis, but have differential effects on the cell cycle and protein prenylation in human myeloma cells.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)